RE: Investor meets presentation17 Dec 2022 16:12
Well I'm back in, after my last post selling many years ago. I was part of the initial investors from the Swedish through to the us regulatory clearance.
Having now done the diligence on the business partnership it seems a fantastic opportunity.
No only is the trade very appealing at 6p but the investment case as an equity is exceptional.
The analysis on this board is very helpful. The only point I would add is that the partner now can sell a box of pills for $200 dollars or so vs iron generics pricing until 2035, to me it is a no brainer that they will push this partnership now. Gla , will be an interesting year ahead . The only thorn is that potential $10m loan , with potential security attached to it, albeit I expect in a liquidation Simone would pay that off to acquire the patents happily now - meaning the holder shouldn't want to see control through default